www.lifescienceevents.com/pain2016

 This event will discuss emerging research relating to the physiology, psychology and pharmacology of pain, and its assessment and management.

Chronic pain is a devastating health problem, and currently available treatments, including opioids and NSAIDS, often lack adequate efficacy leaving pain unrelieved.  Tracey Ignatowski, PhD,  (Assistant Professor of the Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo), is the lead investigator of several studies demonstrating that heightened levels of the immune signalling protein, TNF-α, in the brain are a viable target for analgesia. Dr. Ignatowksi remarks, “Our understanding of the regulation of brain function and neuropathic pain by the immune system may be of fundamental importance to advancing our ability to provide new ways to help patients with intractable neurological disorders.”

While Professor Marino Convertino (University of North Carolina, USA) will discuss a unique signalling mechanism for opioid-dependent pain hypersensitivity. “The elucidation of this unique signalling mechanism provides a platform for the development of novel pharmacological strategies and/or therapeutic protocols involving the use of opiates and beta blockers.”

Dr Pippa Hawley (BC Cancer Agency, Vancouver, Canada) will talk about how the prognosis of patients receiving a cancer diagnosis has changed quite dramatically over the last few years, and that we have to think more about cancer as a chronic disease than ever before. “Non-opioid methods of cancer pain management need to be given a much higher priority in those with long life expectancies, and we as prescribers need to be much more alert to the emergence of addiction as a clinically relevant problem in 21^st century cancer patients.”

Professor Graeme Jones (University of Tasmania, Hobart TAS, Australia) will review the evidence regarding pain in osteoarthritis and the implications for therapy. “Pain due to arthritis is extremely common in people aged over 50. Recent studies have shown that this pain has multiple causes. This, in turn, is leading to better treatment outcomes as therapies can be fine tuned so they best target the cause of the pain.”

While Dr. Luana Colloca, (University of Maryland School of Medicine, Baltimore, USA) will discuss placebo analgesia as a model to produce pain relief in individuals by virtue of expectations and anticipations of a benefit. Learned placebo analgesic effects can be elicited in patients suffering from pain disorders even when pain appears to be refractory to conventional pharmacological interventions .

Other talks include – Physical pain threshold and tolerance in self-harm (Dr. Olivia J. Kirtley, University of Glasgow, Glasgow, United Kingdom), Protective responses in pain: a closer look at perceptions of stiffness in chronic back pain (Dr. Tasha Stanton, University of South Australia) and Phantom limb pain in lower limb amputees (Dr Cliff Richardson, University of Manchester, UK).

Who Should Attend:This event is aimed at research scientists, physicians and pharmaceutical professionals working on both basic pain research and clinical aspects of pain, including pain management.

The event will be recorded and available for all registered delegates up to a month after the event.  So if you can’t manage all the days, or the different time zones, you can still have access to the full event.

Invited speakers and their talks include:

A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event.  Furthermore, you no longer have to worry about travel or accommodation expenses,  or any arrangements you have which clash with our events.